Status:
NOT_YET_RECRUITING
Evaluation of a Vaccine Chatbot on HPV Vaccine Confidence and Hesitancy
Lead Sponsor:
Fudan University
Collaborating Sponsors:
Merck Sharp & Dohme LLC
Conditions:
HPV Vaccine
Eligibility:
FEMALE
15-26 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to learn if a chatbot powered by artificial intelligence works to improve HPV vaccination among females aged 15 to 26 in China. A randomized controlled trial and imp...
Detailed Description
A randomized controlled trial with 2 arms will be conducted to evaluate the effectiveness of an LLM-powered chatbot on improving HPV vaccination among females aged 15 to 26, followed by a pragmatic im...
Eligibility Criteria
Inclusion
- Female, aged 15 to 26 years, inclusive.
- Not previously vaccinated against HPV.
- Reports no contraindications to HPV vaccination.
- Has no mental, visual, or reading impairments that would preclude cooperation with study activities.
- Is willing and able to provide informed consent.
Exclusion
- Male.
- Age under 15 or over 26 years.
- Has a history of prior HPV vaccination.
- Has a known contraindication to HPV vaccination.
- Unable to comply with study procedures.
- Is unwilling or unable to provide informed consent.
Key Trial Info
Start Date :
September 26 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2026
Estimated Enrollment :
1800 Patients enrolled
Trial Details
Trial ID
NCT07200570
Start Date
September 26 2025
End Date
May 1 2026
Last Update
October 1 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.